User: Guest  Login
Title:

Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality.

Document type:
Article; Journal Article
Author(s):
Jank, Marietta; Oechsle, Anna-Lisa; Armann, Jakob; Behrends, Uta; Berner, Reinhard; Chao, Cho-Ming; Diffloth, Natalie; Doenhardt, Maren; Hansen, Gesine; Hufnagel, Markus; Lander, Fabian; Liese, Johannes G.; Muntau, Ania C.; Niehues, Tim; von Both, Ulrich; Verjans, Eva; Weil, Katharina; von Kries, Ruediger; Schroten, Horst
Abstract:
PURPOSE: SARS-CoV-2 infections cause COVID-19 and have a wide spectrum of morbidity. Severe disease courses among children are rare. To date, data on the variability of morbidity in relation to variant of concern (VOC) in children has been sparse and inconclusive. We compare the clinical severity of SARS-CoV-2 infection among children and adolescents in Germany during the Wildtype and Alpha combined, Delta and Omicron phases of the COVID-19 pandemic. METHODS: Comparing risk of COVID-19-related hospitalization, intensive care unit (ICU) admission and death due to COVID-19 in children and adolescents, we used: (1) a multi-center seroprevalence study (SARS-CoV-2-KIDS study); (2) a nationwide registry of pediatric patients hospitalized with SARS-CoV-2 infections; and (3) compulsory national reporting for RT-PCR-confirmed SARS-CoV-2 infections in Germany. RESULTS: During the Delta predominant phase, risk of COVID-19-related hospitalization among all SARS-CoV-2 seropositive children was 3.35, ICU admission 1.19 and fatality 0.09 per 10,000; hence about halved for hospitalization and ICU admission and unchanged for deaths as compared to the Wildtype- and Alpha-dominant period. The relative risk for COVID-19-related hospitalization and ICU admission compared to the alpha period decreased during Delta [0.60 (95% CI 0.54; 0.67) and 0.51 (95% CI 0.42; 0.61)] and Omicron [0.27 (95% CI 0.24; 0.30) and 0.06 (95% CI 0.05; 0.08)] period except for the < 5-year-olds. The rate of case fatalities decreased slightly during Delta, and substantially during Omicron phase. CONCLUSION: Morbidity caused by SARS-CoV-2 infections among children and adolescents in Germany decreased over the course of the COVID-19 pandemic, as different VOCs) emerged.
Journal title abbreviation:
Infection
Year:
2023
Journal volume:
51
Journal issue:
5
Pages contribution:
1357-1367
Fulltext / DOI:
doi:10.1007/s15010-023-01996-y
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/36787015
Print-ISSN:
0300-8126
TUM Institution:
611; Klinik und Poliklinik für Kinder- und Jugendmedizin (Prof. Hauer)
 BibTeX